Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen 

 

September 28, 2012 - (Osiris) - "Osiris Therapeutics, Inc. today announced the conclusion of its collaboration with Genzyme, a Sanofi company. As the Collaboration Agreement is now ended, all rights to Prochymal® and ChondrogenTM worldwide revert back to Osiris. Osiris is now free to commercialize or enter into commercialization agreements for Prochymal and Chondrogen with other parties without limitation."  Read Full Article

 

Posted on 8-Oct-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: